The realistic timeline Based on the current state of the clinical program, regulatory precedent, and publicly available information from Eli Lilly, here is the most realistic projection: Mid to late 2026: Remaining TRIUMPH, TRANSCEND, and SYNERGY Phase 3 results are reported
WW provides more resources and guidelines, so its better for people who need a structured program
Canadians should verify that any supplier provides third-party purity testing, ideally HPLC and mass spectrometry verification
There was also two RCTs with a total of 66 participants which showed that L-carnitine supplementation was related to a mean decrease in systolic blood pressure by 7.41mmHg
Schedule a consultation to see if GLP-1 therapy is right for you
Allergen Immunotherapy: Current and Future Trends